SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile shares are facing significant volatility following an 'off-nominal' orbital insertion of its BlueBird 7 satellite by Blue Origin's New Glenn rocket. While the community is actively debating the potential for an orbital recovery versus a total loss, the long-term investment thesis remains anchored by the company's insurance coverage and its continued production roadmap for subsequent satellites.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is seeing significant market momentum driven by its high-profile partnerships with NVIDIA and its growing leadership in neutral-atom quantum technology, leading to widespread community debate regarding valuation compared to quantum peers. Traders are actively monitoring technical breakouts and potential share unlock events, with many investors maintaining a high-conviction, long-term outlook on the stock's potential as a foundational quantum infrastructure play.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is drawing significant investor attention as analysts upgrade price targets, citing accelerating AI infrastructure demand and potential long-term benefits from custom silicon and optical networking partnerships. The community remains actively focused on Marvell's role in scaling hyperscale AI capacity, with many retail bulls highlighting the company's technical breakout as a signal of sustained momentum.

Sidus Space, Inc. is a space-as-a-service company. The firm focuses on commercial satellite design, manufacture, launch planning, mission operations and in-orbit support, and data collection with a vision to demonstrate space operations for new technologies, and deliver data and predictive analytics to both domestic and global customers. The company was founded by Carol M. Craig on July 17, 2012 and is headquartered in Merritt Island, FL.

Sidus Space Inc - Ordinary Shares - Class A

Sidus Space is experiencing significant volatility and social media attention following the announcement of a large registered direct offering, leading to intense debate among investors about the company's long-term growth potential versus short-term dilution risks. The community remains heavily focused on the stock's role as a geopolitical hedge in the space sector and its ongoing contract partnerships, which continue to drive speculation despite the downward price pressure from the capital raise.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical is experiencing high volatility and intense community speculation driven by a presidential executive order aimed at fast-tracking research into ibogaine for mental health treatment. Investors are closely monitoring the stock's low float and institutional interest, leading to heated debates between bulls anticipating a short squeeze and skeptics warning of a potential sell-the-news event.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as investors debate the potential Phase 3 data for its lead oncology asset, GPS, while closely watching the upcoming AACR conference for disclosures on SLS009. The community remains deeply divided, with bulls highlighting successful clinical milestones and a potential buyout opportunity, while bears voice significant concerns regarding trial design, dosing modifications, and long-term financial viability.

Schmid Group NV provides industrial equipment and services. It operates through following Technical equipment and processes; and Spare parts and services segments. The Technical equipment and processes segment includes mainly the sale of machines including installation and extended warranties. The Spare parts and services segment includes the sale of spare parts as well as services including repairs, modifications of machines and inspections. The company was founded in 1864 and is headquartered in Freudenstadt, Germany.

SCHMID Group N.V. - Ordinary Shares - Class A

SCHMID Group N.V.

SCHMID Group is generating significant volatility as the community debates the disconnect between its advanced glass substrate technology and a precarious financial situation plagued by dilution risk and liquidity concerns. While some investors are betting on the company's potential to play a critical role in AI and semiconductor hardware supply chains, skeptics remain focused on its history of earnings challenges and speculative market sentiment.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is experiencing a surge in market activity driven by the U.S. government's executive order to fast-track research and regulatory review of psychedelic-based therapies. The stock is a primary focus for community members who are actively debating its potential for National Priority Vouchers, upcoming phase 3 trial results, and broader institutional re-rating as the psychedelic biotech sector gains significant policy tailwinds.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

Compass Pathways is gaining momentum as investors track the progress of its late-stage psilocybin program, COMP360, particularly following a White House executive order aimed at accelerating research and access to psychedelic-based mental health treatments. The community is actively discussing the potential for fast-tracked regulatory pathways and the stock's position as a leader in the sector, as traders weigh policy tailwinds against broader clinical development timelines.

Evommune, Inc. is a clinical-stage biotechnology company. It engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pena, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Palo Alto, CA.

Evommune Inc.

Evommune Inc

Evommune is surging as investors react to positive Phase 2a trial data for its atopic dermatitis treatment, with the community actively debating whether the rally is a sustainable breakout or a speculative short-squeeze candidate. Traders are closely monitoring the stock's momentum, with many focused on potential upside triggers and analyst price target revisions following the clinical milestone.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
